pentoxifylline tablet, extended release
aphena pharma solutions - tennessee, llc - pentoxifylline (unii: sd6qct3tsu) (pentoxifylline - unii:sd6qct3tsu) - pentoxifylline extended-release tablets, usp are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. pentoxifylline can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease. pentoxifylline should not be used in patients with recent cerebral and/or retinal hemorrhage or in patients who have previously exhibited intolerance to this product or methylxanthines such as caffeine, theophylline, and theobromine.
trental 400 mg modified-release, coated tablets. 400 milligram modified-release tablets
sanofi-aventis ireland limited t/a sanofi - pentoxifylline - modified-release tablets - 400 milligram
trental 400 modified-release tablets
neuraxpharm uk ltd - pentoxifylline - modified-release tablet - 400mg
cerator extended-release tablet 400mg
medispec (m) sdn.bhd - pentoxifylline -
torental 400 mg prolonged-release tablet
pi pharma - pentoxifylline - prolonged-release tablet - 400 mg - pentoxifylline 400 mg - pentoxifylline
torental 400 mg prolonged-release tablet
orifarm - pentoxifylline - prolonged-release tablet - 400 mg - pentoxifylline 400 mg - pentoxifylline
trental tab 400mg tablet (extended-release)
hoechst canada inc. - pentoxifylline - tablet (extended-release) - 400mg - pentoxifylline 400mg - hemorrheologic agents
trental srt 400mg tablet (extended-release)
hoechst roussel canada inc. - pentoxifylline - tablet (extended-release) - 400mg - pentoxifylline 400mg - hemorrheologic agents
pentoxifylline 400mg modified-release tablets
alliance healthcare (distribution) ltd - pentoxifylline - modified-release tablet - 400mg
pentoxifylline 400mg modified-release tablets
a a h pharmaceuticals ltd - pentoxifylline - modified-release tablet - 400mg